Literature DB >> 15273472

Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality.

A L Dugan1, W B Malarkey, S Schwemberger, E C Jauch, C K Ogle, N D Horseman.   

Abstract

In this study, we measured serum prolactin (PRL), cortisol, growth hormone, interleukin (IL)-1beta, IL-6, IL-8, IL-10, IL-12, and tumor necrosis factor-alpha in patients admitted with small-to-moderate burn injuries. Serum samples were obtained at the time of admission from 49 adult male burn patients with ages ranging from 18 to 91 years and TBSA ranging from 0.001 to 60%. The levels of serum PRL, IL-8, IL-6, and IL-1beta correlated positively with the TBSA, whereas only serum IL-8 levels correlated positively with fatality. Each of these factors were increased at least 2-fold at the higher burn severity. Not surprisingly, there was a large degree of variability in the hormone and cytokine levels in this patient population, which presumably reflects individual levels of stress, as well as other physiological variables. We also studied relationships between serum hormone levels and serum cytokine levels in this context. Linear regression analysis revealed a significant positive correlation between the serum PRL level and the levels of IL-10, IL-6, and IL-8. These results indicate that PRL responds to burn injury at early time points and that a subset of cytokines are involved in the early response to burn injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273472     DOI: 10.1097/01.bcr.0000124785.32516.cb

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  9 in total

Review 1.  Prolactin receptor in regulation of neuronal excitability and channels.

Authors:  Mayur J Patil; Michael A Henry; Armen N Akopian
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

2.  Adult patients are more catabolic than children during acute phase after burn injury: a retrospective analysis on muscle protein kinetics.

Authors:  Demidmaa Tuvdendorj; David L Chinkes; Xiao-Jun Zhang; Arny A Ferrando; Itoro E Elijah; Ronald P Mlcak; Celeste C Finnerty; Robert R Wolfe; David N Herndon
Journal:  Intensive Care Med       Date:  2011-06-07       Impact factor: 17.440

3.  Lack of Th17 cell generation in patients with severe burn injuries.

Authors:  Akihito Inatsu; Mari Kogiso; Marc G Jeschke; Akira Asai; Makiko Kobayashi; David N Herndon; Fujio Suzuki
Journal:  J Immunol       Date:  2011-08-05       Impact factor: 5.422

4.  Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia.

Authors:  Phoebe E Scotland; Mayur Patil; Sergei Belugin; Michael A Henry; Vincent Goffin; Kenneth M Hargreaves; Armen N Akopian
Journal:  Eur J Neurosci       Date:  2011-07-21       Impact factor: 3.386

5.  S179D prolactin diminishes the effects of UV light on epidermal gamma delta T cells.

Authors:  Esther A Guzmán; John L Langowski; Ariel De Guzman; H Konrad Muller; Ameae M Walker; Laurie B Owen
Journal:  Mol Cell Endocrinol       Date:  2007-09-11       Impact factor: 4.102

6.  Serum IL-18 is increased at early postburn period in moderately burned patients.

Authors:  Y Kenan Coban; Murat Aral
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 7.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

8.  Measurement of tissue cortisol levels in patients with severe burns: a preliminary investigation.

Authors:  Jeremy Cohen; Renae Deans; Andrew Dalley; Jeff Lipman; Michael S Roberts; Bala Venkatesh
Journal:  Crit Care       Date:  2009-11-27       Impact factor: 9.097

Review 9.  Biomarkers in community-acquired pneumonia: a state-of-the-art review.

Authors:  Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Elyara F Pacheco; Karoline Dalla Rosa
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.